indoramin has been researched along with Prostatic Hyperplasia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 5 (71.43) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I | 1 |
Bunker, CB; Farrell, AM | 1 |
Clifford, GM; Farmer, RD | 1 |
Chow, W; Das, G; Hahn, D; Henshaw, R; Sandhu, D; Slaney, P; Wells, P | 1 |
Abrams, P; Stott, MA | 1 |
Dunn, M; Iacovou, JW | 1 |
3 review(s) available for indoramin and Prostatic Hyperplasia
Article | Year |
---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
[Alpha blockers in the treatment of benign hyperplasia of the prostate].
Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 1997 |
Medical therapy for benign prostatic hyperplasia: a review of the literature.
Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin | 2000 |
3 trial(s) available for indoramin and Prostatic Hyperplasia
Article | Year |
---|---|
Multicentre controlled trial of indoramin in the symptomatic relief of benign prostatic hypertrophy.
Topics: Aged; Aged, 80 and over; Double-Blind Method; Humans; Indoles; Indoramin; Male; Middle Aged; Multicenter Studies as Topic; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Urination Disorders | 1990 |
Indoramin in the treatment of prostatic bladder outflow obstruction.
Topics: Double-Blind Method; Humans; Indoramin; Male; Prostatic Hyperplasia; Urinary Bladder; Urinary Bladder Neck Obstruction; Urodynamics | 1991 |
Indoramin--an effective new drug in the management of bladder outflow obstruction.
Topics: Aged; Double-Blind Method; Humans; Indoles; Indoramin; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Urinary Bladder; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics | 1987 |
1 other study(ies) available for indoramin and Prostatic Hyperplasia
Article | Year |
---|---|
Cutaneous eruption due to indoramin.
Topics: Adrenergic alpha-Antagonists; Drug Eruptions; Humans; Indoramin; Male; Middle Aged; Prostatic Hyperplasia | 1998 |